Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to ...

A human cell culture model of the lung’s most important immune cells, alveolar macrophages, helped make a key finding that is ...

Targeting self-renewal, the process by which stem cells divide and generate progeny ... to be selectively cytotoxic to primary LSCs from AML and other leukemias within 2 h after drug exposure ...

AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells, which are capable of self-renewal, proliferation and differentiation into malignant ...

A study utilizing alveolar macrophage-like (AML) cells revealed that tumor necrosis factor (TNF) is critical for fighting ...

Patients with Acute Myeloid Leukemia (AML ... company of Clinical Trials Arena. Cell therapies are used as supportive products after hematopoietic stem cell transplants (HSCT) that aim to either ...

An August 2024 update to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for treatment of ...

Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...

While the use of elivaldogene autotemcel (eli-cel; Skysona) gene therapy has demonstrated long-term efficacy in patients with ...

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a Notice of ...

Photovoltaic cell maker Day4 Energy (TSE:DFE) has struck a deal with Taiwan-based solar company Ever Energy to make solar panel cells using the company’s own DNA technology. Vancouver-based Day4 ...